angiotensin ii has been researched along with Dementia in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chambers, LC; Dorrance, AM; Jackson, WF; Yen, M | 1 |
Barthold, D; Crane, PK; Gray, SL; Larson, EB; Marcum, ZA; Moll van Charante, EP; Richard, E; van Dalen, JW; van Gool, WA | 1 |
Bornstein, SR; Chakrabarti, S; Graessler, J; Kopprasch, S; Saha, S | 1 |
Ho, JK; Nation, DA | 1 |
Csiszar, A; Gautam, T; Koller, A; Mitschelen, M; Sonntag, WE; Sosnowska, D; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z | 1 |
Middeke, M | 1 |
Appleyard, SM; Benoist, CC; Bule-Ghogare, JM; Harding, JW; Kawas, LH; McCoy, AT; Wayman, GA; Wright, JW; Zhu, M | 1 |
Olesen, J | 1 |
2 review(s) available for angiotensin ii and Dementia
Article | Year |
---|---|
Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.
Topics: Angiotensin I; Angiotensin II; Animals; Cognition Disorders; Databases, Bibliographic; Dementia; Disease Models, Animal; Humans; Memory, Short-Term; Peptide Fragments | 2018 |
[Hypertensiology 2010].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dementia; Drug Resistance; Humans; Hypertension; Hypertension, Renal; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reference Values; Vaccines | 2010 |
1 trial(s) available for angiotensin ii and Dementia
Article | Year |
---|---|
Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dementia; Female; Humans; Hypertension; Incidence; Male; Sodium Chloride Symporter Inhibitors | 2021 |
5 other study(ies) available for angiotensin ii and Dementia
Article | Year |
---|---|
Female mice are protected from impaired parenchymal arteriolar TRPV4 function and impaired cognition in hypertension.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Cognition; Cognitive Dysfunction; Dementia; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; TRPV Cation Channels | 2023 |
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Cell Proliferation; Cognitive Dysfunction; Dementia; Diabetes Complications; Glycosylation; Humans; Janus Kinase 2; Lipoproteins; Models, Biological; Oxidation-Reduction; Signal Transduction | 2017 |
IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice.
Topics: Aging; Angiotensin II; Animals; Biomarkers; Blood-Brain Barrier; Cerebrovascular Circulation; Dementia; Disease Models, Animal; Encephalitis; Hippocampus; Homeostasis; Hypertension; Insulin-Like Growth Factor I; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Microglia; Middle Cerebral Artery; TRPC Cation Channels; Vasoconstrictor Agents | 2014 |
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.
Topics: Angiotensin II; Animals; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Dementia; Dendritic Spines; Half-Life; Hippocampus; Hydrogen Bonding; Immunohistochemistry; In Vitro Techniques; Male; Maze Learning; Microsomes, Liver; Neurogenesis; Nootropic Agents; Oligopeptides; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Synapses; Transfection | 2013 |
Quantitative evaluation of normal and pathologic cerebral blood flow regulation to perfusion pressure. Changes in man.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Brain Diseases; Carbon Dioxide; Cerebral Angiography; Cerebrovascular Circulation; Cerebrovascular Disorders; Dementia; Epilepsy; Female; Humans; Hysteria; Male; Middle Aged; Norepinephrine; Perfusion; Trimethaphan; Vascular Resistance; Xenon | 1973 |